These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34681654)

  • 1. Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment.
    Francipane MG; Douradinha B; Chinnici CM; Russelli G; Conaldi PG; Iannolo G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
    Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Zika Virus: New Option for Glioblastoma Treatment.
    Zhou C; Chen Q; Chen Y; Qin CF
    DNA Cell Biol; 2023 Jun; 42(6):267-273. PubMed ID: 36350682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika virus has oncolytic activity against glioblastoma stem cells.
    Zhu Z; Gorman MJ; McKenzie LD; Chai JN; Hubert CG; Prager BC; Fernandez E; Richner JM; Zhang R; Shan C; Tycksen E; Wang X; Shi PY; Diamond MS; Rich JN; Chheda MG
    J Exp Med; 2017 Oct; 214(10):2843-2857. PubMed ID: 28874392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zika virus infection induces MiR34c expression in glioblastoma stem cells: new perspectives for brain tumor treatments.
    Iannolo G; Sciuto MR; Cuscino N; Pallini R; Douradinha B; Ricci Vitiani L; De Maria R; Conaldi PG
    Cell Death Dis; 2019 Mar; 10(4):263. PubMed ID: 30890698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.
    Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zika virus and brain cancer: Can Zika be an effective treatment for brain cancer? A systematic review.
    de Sena Barbosa MG; Messias BR; Tatit RT; de Paula MCG; Júnior VBS; Braga MGB; Santos CVM; Cobos LD; da Silva VO; Figueiredo EG; Rabelo NN; Chaurasia B
    Oncotarget; 2024 Sep; 15():662-673. PubMed ID: 39347716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
    Nair S; Mazzoccoli L; Jash A; Govero J; Bais SS; Hu T; Fontes-Garfias CR; Shan C; Okada H; Shresta S; Rich JN; Shi PY; Diamond MS; Chheda MG
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.
    Sgubin D; Wakimoto H; Kanai R; Rabkin SD; Martuza RL
    Stem Cells Transl Med; 2012 Apr; 1(4):322-32. PubMed ID: 23197811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin α
    Zhu Z; Mesci P; Bernatchez JA; Gimple RC; Wang X; Schafer ST; Wettersten HI; Beck S; Clark AE; Wu Q; Prager BC; Kim LJY; Dhanwani R; Sharma S; Garancher A; Weis SM; Mack SC; Negraes PD; Trujillo CA; Penalva LO; Feng J; Lan Z; Zhang R; Wessel AW; Dhawan S; Diamond MS; Chen CC; Wechsler-Reya RJ; Gage FH; Hu H; Siqueira-Neto JL; Muotri AR; Cheresh DA; Rich JN
    Cell Stem Cell; 2020 Feb; 26(2):187-204.e10. PubMed ID: 31956038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells
    Kaid C; Goulart E; Caires-Júnior LC; Araujo BHS; Soares-Schanoski A; Bueno HMS; Telles-Silva KA; Astray RM; Assoni AF; Júnior AFR; Ventini DC; Puglia ALP; Gomes RP; Zatz M; Okamoto OK
    Cancer Res; 2018 Jun; 78(12):3363-3374. PubMed ID: 29700002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors.
    Novaes GM; Lima C; Longo C; Machado PH; Silva TP; Olberg GGO; Módolo DG; Pereira MCL; Santos TG; Zatz M; Lagares D; de Franco M; Ho PL; Bulstrode H; Okamoto OK; Kaid C
    Mol Ther; 2024 Feb; 32(2):440-456. PubMed ID: 38213031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells.
    Victorio CBL; Novera W; Ganasarajah A; Ong J; Thomas M; Wu J; Toh HSY; Sun AX; Ooi EE; Chacko AM
    J Transl Med; 2024 Feb; 22(1):126. PubMed ID: 38308299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
    Wakimoto H; Kesari S; Farrell CJ; Curry WT; Zaupa C; Aghi M; Kuroda T; Stemmer-Rachamimov A; Shah K; Liu TC; Jeyaretna DS; Debasitis J; Pruszak J; Martuza RL; Rabkin SD
    Cancer Res; 2009 Apr; 69(8):3472-81. PubMed ID: 19351838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting role of glioma stem cells for glioblastoma multiforme.
    Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
    Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment.
    Tinnirello R; Chinnici CM; Miceli V; Busà R; Bulati M; Gallo A; Zito G; Conaldi PG; Iannolo G
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.
    Garcia G; Chakravarty N; Paiola S; Urena E; Gyani P; Tse C; French SW; Danielpour M; Breunig JJ; Nathanson DA; Arumugaswami V
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells.
    Baugh R; Khalique H; Page E; Lei-Rossmann J; Wan PK; Johanssen T; Ebner D; Ansorge O; Seymour LW
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Serial Systemic and Intratumoral Injections of Oncolytic ZIKV
    Ferreira RO; Granha I; Ferreira RS; Bueno HS; Okamoto OK; Kaid C; Zatz M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.
    Tobias AL; Thaci B; Auffinger B; Rincón E; Balyasnikova IV; Kim CK; Han Y; Zhang L; Aboody KS; Ahmed AU; Lesniak MS
    Stem Cells Transl Med; 2013 Sep; 2(9):655-66. PubMed ID: 23926209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.